Eisai
4523.T
#2011
Rank
NZ$13.78 B
Marketcap
$48.91
Share price
-0.53%
Change (1 day)
-36.38%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total assets

Total assets on the balance sheet as of March 2024 : NZ$16.27 Billion

According to Eisai's latest financial reports the company's total assets are NZ$16.27 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Eisai - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-03-31NZ$15.12 B3.82%
2022-03-31NZ$14.57 B3.25%
2021-03-31NZ$14.11 B-13.74%
2020-03-31NZ$16.35 B15.27%
2019-03-31NZ$14.19 B4.13%
2018-03-31NZ$13.62 B3.51%
2017-03-31NZ$13.16 B4.86%
2016-03-31NZ$12.55 B7.27%
2015-03-31NZ$11.70 B7.22%
2014-03-31NZ$10.91 B-12.97%
2013-03-31NZ$12.54 B-15.05%
2012-03-31NZ$14.76 B-10.56%
2011-03-31NZ$16.51 B-0.92%
2010-03-31NZ$16.66 B-19.53%
2009-03-31NZ$20.70 B44.41%
2008-03-31NZ$14.34 B52.55%
2007-03-31NZ$9.40 B-9.05%
2006-03-31NZ$10.33 B19.06%
2005-03-31NZ$8.68 B-2.05%
2004-03-31NZ$8.86 B-2.13%
2003-03-31NZ$9.05 B-4.59%
2002-03-31NZ$9.49 B-13.13%
2001-03-31NZ$10.92 B